No Data
No Data
"Facial Age" AI Test, utilized by doctors.
The Artificial Intelligence (AI) model "FaceAge," which identifies signs of aging on the face, seems to have utilized tens of thousands of patient photographs and publicly available image databases for training. A study conducted by a team led by cancer specialist Raymond Mack reported that FaceAge's algorithm was shown to be more accurate than doctors in predicting the life expectancy of cancer patients. <6702> Fujitsu <7046> TDSE <401
Stocks News Web - New Year’s gift focus stocks (1) Continuing high growth with both EC and Lear.
Istyle <3660.T> is expected to continue its high level of revenue growth as a small-cap stock, and it should be marked as such. It is capturing the expanding cosmetics market through both online and offline channels. The company is known for its beauty information site '@cosme' in Japan, and it is also actively expanding its physical store presence. With a vast amount of data from rankings and reviews, it generates revenue from advertising income from manufacturers and product sales.
Mr. Mask's xAI is rapidly catching up to OpenAI.
It has been reported that Elon Musk has been focusing on rapidly growing his artificial intelligence (ai) startup xAI over the past year. In a plan to establish a new datacenter, he urged contractors to complete it in an unprecedentedly short period of just a few months, and regarding the new facility, Musk expressed confidence that by December, xAI will contribute to providing the world's strongest ai "in every indicator".
SoftBank Group aims to acquire shares from OpenAI employees.
[Generating AI] Softbank Group <9984> is reportedly aiming to increase its investment ratio by acquiring up to $1.5 billion (approximately 230 billion yen) worth of shares from employees of the US OpenAI, as multiple sources have revealed. It is reported that Softbank Group's offer for share acquisition is expected to close within the week. <6702> Fujitsu <7046> TDSE <4011> Headwaters.
Avilen: Presentation of financial results for the 3rd quarter of the fiscal year ending 2024/12
Avilen: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
No Data